price
ED
NASDAQ · EDIT
Editas Medicine, Inc.
Healthcare · Biotechnology
$2.79
Down-$0.06 (-2.15%)
Updated Oct 6, 2026, 10:36 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 217.72M
- P/E ratio
- -0.91
- Dividend yield
- 0.00%
- 52-week range
- $1.98 – $3.94
- Volume
- 3.02M
- Avg. volume
- 2.47M
Price performance · EDIT
EDIT price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
EDIT closed at $2.79 after 20 trading sessions, down 7.92% for the selected period.
- Last close
- $2.79
- Period change
- -7.92%
- Period low
- $2.51
- Period high
- $3.03
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $2.62 | $2.81 | $2.555 | $2.79 | 3.02M |
| Oct 2, 2026 | $2.57 | $2.63 | $2.51 | $2.62 | 2.16M |
| Oct 1, 2026 | $2.61 | $2.62 | $2.52 | $2.52 | 1.54M |
| Sep 30, 2026 | $2.61 | $2.72 | $2.55 | $2.57 | 1.63M |
| Sep 29, 2026 | $2.54 | $2.62 | $2.51 | $2.59 | 1.57M |
| Sep 28, 2026 | $2.55 | $2.55 | $2.42 | $2.51 | 2.2M |
| Sep 25, 2026 | $2.76 | $2.78 | $2.57 | $2.58 | 3.12M |
| Sep 24, 2026 | $2.66 | $2.76 | $2.545 | $2.75 | 2.59M |
| Sep 23, 2026 | $3.12 | $3.14 | $2.67 | $2.69 | 5.17M |
| Sep 22, 2026 | $2.86 | $2.93 | $2.805 | $2.92 | 2.3M |
| Sep 21, 2026 | $2.76 | $2.89 | $2.695 | $2.83 | 2.49M |
| Sep 18, 2026 | $2.73 | $2.825 | $2.68 | $2.70 | 17.03M |
| Sep 17, 2026 | $2.80 | $2.945 | $2.71 | $2.72 | 3.52M |
| Sep 16, 2026 | $2.65 | $2.73 | $2.63 | $2.71 | 2.49M |
| Sep 15, 2026 | $2.70 | $2.71 | $2.59 | $2.63 | 1.68M |
| Sep 14, 2026 | $2.72 | $2.815 | $2.66 | $2.74 | 1.69M |
| Sep 11, 2026 | $2.68 | $2.72 | $2.62 | $2.70 | 2.46M |
| Sep 10, 2026 | $2.77 | $2.77 | $2.62 | $2.65 | 2.55M |
| Sep 9, 2026 | $3.06 | $3.06 | $2.77 | $2.77 | 2.96M |
| Sep 8, 2026 | $3.20 | $3.215 | $3.01 | $3.03 | 2.28M |
Latest EDIT news
The latest Smart Investors Daily articles mentioning EDIT.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…

